Target intelligence / Profile preview

Intestinal epithelial membrane

Molecular classification
Other
01

Overview

The intestinal epithelial membrane is a complex cellular barrier that separates the intestinal lumen from the underlying tissues and systemic circulation (Groschwitz & Hogan, 2009). It is primarily composed of a single layer of epithelial cells, including enterocytes, goblet cells, and enteroendocrine cells, which are held together by tight junctions to regulate paracellular permeability (Turner, 2009). This structure serves a dual role: it facilitates the selective absorption of nutrients, water, and electrolytes while acting as a formidable defense against pathogens, toxins, and undigested food particles (Odenwald & Turner, 2017). In pharmacology, the membrane is a critical site for drug absorption and first-pass metabolism, housing numerous transporters like P-glycoprotein and enzymes like CYP3A4 (StatPearls, 2023). While not a single molecular target, it contains various receptors and channels that are targeted by drugs to treat gastrointestinal motility and inflammatory disorders (Nature Reviews, 2012). Pathological breakdown of this barrier, often referred to as leaky gut, is associated with conditions such as inflammatory bowel disease, celiac disease, and systemic inflammation (Okumura & Takeda, 2017).

Other names
Intestinal mucosaIntestinal epithelial barrierGut barrierEnterocyte membraneIntestinal epithelium
02

Mechanism of action

Drugs interact with the intestinal epithelial membrane by modulating tight junction integrity, activating apical or basolateral ion channels and receptors, or providing a physical cytoprotective layer over the mucosa (Odenwald & Turner, 2017; StatPearls, 2023).

03

Biological functions

AbsorptionBarrier functionSecretionImmune responseMetabolism
04

Disease associations

InflammationInfectionCeliac diseaseMalabsorption syndromeIrritable bowel syndrome
05

Safety considerations

Altered drug bioavailabilitySystemic toxicity due to barrier breachGastrointestinal irritationElectrolyte and fluid imbalance
06

Interacting drugs

Mesalamine

5 more in the full profile.

07

Biomarkers

ZonulinFecal calprotectinCitrullineIntestinal fatty acid-binding protein (I-FABP)

Beyond the preview

Go deeper on Intestinal epithelial membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call